Prospective validation study of a predictive score for operability of recurrent ovarian cancer: the Multicenter Intergroup Study DESKTOP II. A project of the AGO Kommission OVAR, AGO Study Group, NOGGO, AGO-Austria, and MITO

P Harter; J Sehouli; A Reuss; A Hasenburg; Giovanni Scambia; D Cibula; S Mahner; I Vergote; A Reinthaller; A Burges; L Hanker; M Pölcher; C Kurzeder; U Canzler; Ku Petry; A Obermair; E Petru; B Schmalfeldt; Domenica Lorusso; A. Du Bois

doi:10.1097/IGC.0b013e31820aaafd

Prospective validation study of a predictive score for operability of recurrent ovarian cancer: the Multicenter Intergroup Study DESKTOP II. A project of the AGO Kommission OVAR, AGO Study Group, NOGGO, AGO-Austria, and MITO

P Harter, J Sehouli, A Reuss, A Hasenburg, Giovanni Scambia, D Cibula, S Mahner, I Vergote, A Reinthaller, A Burges, L Hanker, M Pölcher, C Kurzeder, U Canzler, Ku Petry, A Obermair, E Petru, B Schmalfeldt, Domenica Lorusso, A. Du Bois

University of Freiburg

Risultato della ricerca: Contributo in rivista › Articolo

172 Citazioni (Scopus)

Abstract

The DESKTOP I trial proposed a score for the prediction of complete cytoreduction in recurrent ovarian cancer. Resectability was assumed if 3 factors were present: (1) complete resection at first surgery, (2) good performance status, and (3) absence of ascites. The DESKTOP II trial was planned to verify this hypothesis prospectively in a multicenter setting.

Lingua originale	Inglese
pagine (da-a)	289-295
Numero di pagine	7
Rivista	International Journal of Gynecological Cancer
Volume	21
Numero di pubblicazione	2
DOI	https://doi.org/10.1097/IGC.0b013e31820aaafd
Stato di pubblicazione	Pubblicato - 2011
Pubblicato esternamente	Sì

Keywords

80 and over
Adult
Aged
Female
Health Status Indicators
Humans
Local
Middle Aged
Neoplasm Recurrence
Ovarian Neoplasms
Prospective Studies

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.1097/IGC.0b013e31820aaafd

Altri file e collegamenti

Link a IRIS PubliCatt

Fingerprint

Entra nei temi di ricerca di 'Prospective validation study of a predictive score for operability of recurrent ovarian cancer: the Multicenter Intergroup Study DESKTOP II. A project of the AGO Kommission OVAR, AGO Study Group, NOGGO, AGO-Austria, and MITO'. Insieme formano una fingerprint unica.

Cita questo

Harter, P., Sehouli, J., Reuss, A., Hasenburg, A., Scambia, G., Cibula, D., Mahner, S., Vergote, I., Reinthaller, A., Burges, A., Hanker, L., Pölcher, M., Kurzeder, C., Canzler, U., Petry, K., Obermair, A., Petru, E., Schmalfeldt, B., Lorusso, D., & Du Bois, A. (2011). Prospective validation study of a predictive score for operability of recurrent ovarian cancer: the Multicenter Intergroup Study DESKTOP II. A project of the AGO Kommission OVAR, AGO Study Group, NOGGO, AGO-Austria, and MITO. International Journal of Gynecological Cancer, 21(2), 289-295. https://doi.org/10.1097/IGC.0b013e31820aaafd

@article{9729af7f94cb4039a2d643880384f7dd,

title = "Prospective validation study of a predictive score for operability of recurrent ovarian cancer: the Multicenter Intergroup Study DESKTOP II. A project of the AGO Kommission OVAR, AGO Study Group, NOGGO, AGO-Austria, and MITO",

abstract = "The DESKTOP I trial proposed a score for the prediction of complete cytoreduction in recurrent ovarian cancer. Resectability was assumed if 3 factors were present: (1) complete resection at first surgery, (2) good performance status, and (3) absence of ascites. The DESKTOP II trial was planned to verify this hypothesis prospectively in a multicenter setting.",

keywords = "80 and over, Adult, Aged, Female, Health Status Indicators, Humans, Local, Middle Aged, Neoplasm Recurrence, Ovarian Neoplasms, Prospective Studies, 80 and over, Adult, Aged, Female, Health Status Indicators, Humans, Local, Middle Aged, Neoplasm Recurrence, Ovarian Neoplasms, Prospective Studies",

author = "P Harter and J Sehouli and A Reuss and A Hasenburg and Giovanni Scambia and D Cibula and S Mahner and I Vergote and A Reinthaller and A Burges and L Hanker and M P{\"o}lcher and C Kurzeder and U Canzler and Ku Petry and A Obermair and E Petru and B Schmalfeldt and Domenica Lorusso and {Du Bois}, A.",

year = "2011",

doi = "10.1097/IGC.0b013e31820aaafd",

language = "English",

volume = "21",

pages = "289--295",

journal = "International Journal of Gynecological Cancer",

issn = "1048-891X",

publisher = "Elsevier Inc.",

number = "2",

}

Harter, P, Sehouli, J, Reuss, A, Hasenburg, A, Scambia, G, Cibula, D, Mahner, S, Vergote, I, Reinthaller, A, Burges, A, Hanker, L, Pölcher, M, Kurzeder, C, Canzler, U, Petry, K, Obermair, A, Petru, E, Schmalfeldt, B, Lorusso, D & Du Bois, A 2011, 'Prospective validation study of a predictive score for operability of recurrent ovarian cancer: the Multicenter Intergroup Study DESKTOP II. A project of the AGO Kommission OVAR, AGO Study Group, NOGGO, AGO-Austria, and MITO', International Journal of Gynecological Cancer, vol. 21, n. 2, pagg. 289-295. https://doi.org/10.1097/IGC.0b013e31820aaafd

Prospective validation study of a predictive score for operability of recurrent ovarian cancer: the Multicenter Intergroup Study DESKTOP II. A project of the AGO Kommission OVAR, AGO Study Group, NOGGO, AGO-Austria, and MITO. / Harter, P; Sehouli, J; Reuss, A et al.
In: International Journal of Gynecological Cancer, Vol. 21, N. 2, 2011, pag. 289-295.

Risultato della ricerca: Contributo in rivista › Articolo

TY - JOUR

T1 - Prospective validation study of a predictive score for operability of recurrent ovarian cancer: the Multicenter Intergroup Study DESKTOP II. A project of the AGO Kommission OVAR, AGO Study Group, NOGGO, AGO-Austria, and MITO

AU - Harter, P

AU - Sehouli, J

AU - Reuss, A

AU - Hasenburg, A

AU - Scambia, Giovanni

AU - Cibula, D

AU - Mahner, S

AU - Vergote, I

AU - Reinthaller, A

AU - Burges, A

AU - Hanker, L

AU - Pölcher, M

AU - Kurzeder, C

AU - Canzler, U

AU - Petry, Ku

AU - Obermair, A

AU - Petru, E

AU - Schmalfeldt, B

AU - Lorusso, Domenica

AU - Du Bois, A.

PY - 2011

Y1 - 2011

N2 - The DESKTOP I trial proposed a score for the prediction of complete cytoreduction in recurrent ovarian cancer. Resectability was assumed if 3 factors were present: (1) complete resection at first surgery, (2) good performance status, and (3) absence of ascites. The DESKTOP II trial was planned to verify this hypothesis prospectively in a multicenter setting.

AB - The DESKTOP I trial proposed a score for the prediction of complete cytoreduction in recurrent ovarian cancer. Resectability was assumed if 3 factors were present: (1) complete resection at first surgery, (2) good performance status, and (3) absence of ascites. The DESKTOP II trial was planned to verify this hypothesis prospectively in a multicenter setting.

KW - 80 and over

KW - Adult

KW - Aged

KW - Female

KW - Health Status Indicators

KW - Humans

KW - Local

KW - Middle Aged

KW - Neoplasm Recurrence

KW - Ovarian Neoplasms

KW - Prospective Studies

KW - 80 and over

KW - Adult

KW - Aged

KW - Female

KW - Health Status Indicators

KW - Humans

KW - Local

KW - Middle Aged

KW - Neoplasm Recurrence

KW - Ovarian Neoplasms

KW - Prospective Studies

UR - https://publicatt.unicatt.it/handle/10807/3708

U2 - 10.1097/IGC.0b013e31820aaafd

DO - 10.1097/IGC.0b013e31820aaafd

M3 - Article

SN - 1048-891X

VL - 21

SP - 289

EP - 295

JO - International Journal of Gynecological Cancer

JF - International Journal of Gynecological Cancer

IS - 2

ER -

Harter P, Sehouli J, Reuss A, Hasenburg A, Scambia G, Cibula D et al. Prospective validation study of a predictive score for operability of recurrent ovarian cancer: the Multicenter Intergroup Study DESKTOP II. A project of the AGO Kommission OVAR, AGO Study Group, NOGGO, AGO-Austria, and MITO. International Journal of Gynecological Cancer. 2011;21(2):289-295. doi: 10.1097/IGC.0b013e31820aaafd